Eisler Capital (UK)’s Moderna MRNA Stock Holding History

Eisler Capital (UK)’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-948	Closed	-$112K	–	200
2022 Q3	$112K	Buy	+948	New	+$144K	0.01%	134

Other funds holding MRNA

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Eisler Capital (UK)'s MRNA Position: Q4 2022 in Review

Eisler Capital (UK) sold out of Moderna (MRNA) in Q4 2022, closing a stake of 948 shares — an estimated $112K sold.

Eisler Capital (UK) first reported a position in MRNA in Q3 2022 and held it in 1 quarter. The position peaked at $112K in Q3 2022. 1,071 funds tracked by Wall St. Rank hold MRNA as of Q4 2022.

Eisler Capital (UK) reported no remaining Moderna position as of Q4 2022 after selling out during the quarter.
Eisler Capital (UK) sold 948 Moderna shares in Q4 2022, an estimated $112K.
Eisler Capital (UK) first reported a position in Moderna in Q3 2022 and held it in 1 quarter.
Eisler Capital (UK)'s Moderna position peaked at $112K in Q3 2022.
1,071 funds tracked by Wall St. Rank held Moderna as of Q4 2022.

Based on Eisler Capital (UK)'s 13F filing for Q4 2022, filed 14 Feb 2023.